Literature DB >> 16896148

Effects of immunosuppression on West Nile virus infection in hamsters.

Rosa Mateo1, Shu-Yuan Xiao, Hilda Guzman, Hao Lei, Amelia P A Travassos Da Rosa, Robert B Tesh.   

Abstract

A research study, comparing the pathogenesis of experimental West Nile virus (WNV) infection in immunocompetent and immunosuppressed golden hamsters, is described. Cyclophosphamide was used to immunosuppress the animals. The immunosuppressed hamsters had a prolonged period of viremia, depressed humoral immune response, more extensive and severe pathology, and higher fatality rate than the untreated immunocompetent animals. Histopathological and immunohistochemical studies of tissues from the two groups showed that pathologic changes in the untreated infected animals were confined to the brain and spinal cord, whereas the histopathological changes and WNV antigen distribution in the immunosuppressed animals were much more extensive and diffuse, involving the adrenal, kidney, heart and lung, and brain and spinal cord. Results of this study in the hamster model provide insight into the increased severity of WNV infection observed in immunosuppressed people.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896148

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

Review 1.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.

Authors:  David C Clark; Aaron C Brault; Elizabeth Hunsperger
Journal:  Arch Virol       Date:  2012-05-17       Impact factor: 2.574

2.  Zika virus epidemic in Brazil. I. Fatal disease in adults: Clinical and laboratorial aspects.

Authors:  Raimunda S S Azevedo; Marialva T Araujo; Arnaldo J Martins Filho; Consuelo S Oliveira; Bruno T D Nunes; Ana C R Cruz; Ana G P A C Nascimento; Rita C Medeiros; Cezar A M Caldas; Fernando C Araujo; Juarez A S Quaresma; Barbara C B Vasconcelos; Maria G L Queiroz; Elizabeth S Travassos da Rosa; Daniele F Henriques; Eliana V P Silva; Jannifer O Chiang; Lívia C Martins; Daniele B A Medeiros; Juliana A Lima; Márcio R T Nunes; Jedson F Cardoso; Sandro P Silva; Pei-Yong Shi; Robert B Tesh; Sueli G Rodrigues; Pedro F C Vasconcelos
Journal:  J Clin Virol       Date:  2016-11-05       Impact factor: 3.168

3.  A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.

Authors:  Rebecca L Brocato; Christopher D Hammerbeck; Todd M Bell; Jay B Wells; Laurie A Queen; Jay W Hooper
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

4.  Characterization of the mouse neuroinvasiveness of selected European strains of West Nile virus.

Authors:  Stephanie M Lim; Penelope Koraka; Sander van Boheemen; Jouke M Roose; Dick Jaarsma; David A M C van de Vijver; Albert D M E Osterhaus; Byron E E Martina
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 5.  Syrian Hamster as an Animal Model for the Study on Infectious Diseases.

Authors:  Jinxin Miao; Louisa S Chard; Zhimin Wang; Yaohe Wang
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

6.  Hantavirus infection in type I interferon receptor-deficient (A129) mice.

Authors:  Stuart D Dowall; Victoria A Graham; Marilyn Aram; Stephen Findlay-Wilson; Francisco J Salguero; Kirsty Emery; Roger Hewson
Journal:  J Gen Virol       Date:  2020-10       Impact factor: 3.891

7.  Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.

Authors:  Kate Kosmac; Glenn R Bantug; Ester P Pugel; Djurdjica Cekinovic; Stipan Jonjic; William J Britt
Journal:  PLoS Pathog       Date:  2013-03-07       Impact factor: 6.823

8.  An immunosuppressed Syrian golden hamster model for SARS-CoV infection.

Authors:  Scott R Schaecher; Jennifer Stabenow; Christina Oberle; Jill Schriewer; R Mark Buller; John E Sagartz; Andrew Pekosz
Journal:  Virology       Date:  2008-08-28       Impact factor: 3.616

9.  Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection.

Authors:  David Ben-Nathan; Orly Gershoni-Yahalom; Itzchak Samina; Yevgeny Khinich; Israel Nur; Orgad Laub; Ahuva Gottreich; Michael Simanov; Angel Porgador; Bracha Rager-Zisman; Nadav Orr
Journal:  BMC Infect Dis       Date:  2009-02-17       Impact factor: 3.090

10.  Immunotoxicological evaluation of corn genetically modified with Bacillus thuringiensis Cry1Ah gene by a 30-day feeding study in BALB/c mice.

Authors:  Yan Song; Chunlai Liang; Wei Wang; Jin Fang; Nana Sun; Xudong Jia; Ning Li
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.